Comprehensive Stock Comparison
Compare National Healthcare Properties, Inc. (NHPBP) vs Diversified Healthcare Trust (DHC) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | DHC | 2.8% revenue growth vs NHPBP's 2.3% |
| Quality / Margins | DHC | -18.6% net margin vs NHPBP's -23.0% |
| Stability / Safety | NHPBP | Beta 0.44 vs DHC's 0.75 |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | DHC | +140.3% vs NHPBP's +47.6% |
| Efficiency (ROA) | NHPBP | -4.6% ROA vs DHC's -6.6%, ROIC -4.8% vs -0.9% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
National Healthcare Properties is a real estate investment trust that owns and operates healthcare facilities—primarily seniors housing communities and medical office buildings across the United States. It generates revenue through property leases and rental income from healthcare operators, with seniors housing contributing the majority of its portfolio value. The company's competitive advantage lies in its specialized healthcare real estate expertise and diversified portfolio of mission-critical medical properties that benefit from stable, long-term demand.
Diversified Healthcare Trust is a real estate investment trust that owns and operates healthcare-related properties including medical office buildings, senior living communities, and life science facilities. It generates revenue primarily through property rental income — with medical office properties contributing roughly 60% of net operating income and senior living communities about 40% — along with management fees from its operating partner. The company's competitive advantage lies in its specialized healthcare real estate portfolio and its long-term management relationship with The RMR Group, which provides operational expertise in the healthcare property sector.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
DHC leads in 3 of 6 categories — strongest in Financial Metrics and Profitability & Efficiency. 1 category is tied.
Financial Metrics (TTM)
DHC is the larger business by revenue, generating $1.5B annually — 4.4x NHPBP's $348M. Profitability is closely matched — net margins range from -18.6% (DHC) to -23.0% (NHPBP). On growth, DHC holds the edge at -0.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | NHPBPNational Healthca… | DHCDiversified Healt… |
|---|---|---|
| RevenueTrailing 12 months | $348M | $1.5B |
| EBITDAEarnings before interest/tax | $72M | $292M |
| Net IncomeAfter-tax profit | -$80M | -$286M |
| Free Cash FlowCash after capex | -$125M | -$16M |
| Gross MarginGross profit ÷ Revenue | +36.2% | -16.0% |
| Operating MarginEBIT ÷ Revenue | -4.2% | +2.0% |
| Net MarginNet income ÷ Revenue | -23.0% | -18.6% |
| FCF MarginFCF ÷ Revenue | -35.9% | -1.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.9% | -0.0% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +75.5% |
Valuation Metrics
| Metric | NHPBPNational Healthca… | DHCDiversified Healt… |
|---|---|---|
| Market CapShares × price | — | $1.6B |
| Enterprise ValueMkt cap + debt − cash | — | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | — | -5.68x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 6.88x |
| Price / SalesMarket cap ÷ Revenue | — | 1.06x |
| Price / BookPrice ÷ Book value/share | — | 0.98x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
NHPBP delivers a -12.3% return on equity — every $100 of shareholder capital generates $-12 in annual profit, vs $-17 for DHC. On the Piotroski fundamental quality scale (0–9), NHPBP scores 4/9 vs DHC's 3/9, reflecting mixed financial health.
| Metric | NHPBPNational Healthca… | DHCDiversified Healt… |
|---|---|---|
| ROE (TTM)Return on equity | -12.3% | -17.2% |
| ROA (TTM)Return on assets | -4.6% | -6.6% |
| ROICReturn on invested capital | -4.8% | -0.9% |
| ROCEReturn on capital employed | -7.7% | -0.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 |
| Debt / EquityFinancial leverage | 1.67x | — |
| Net DebtTotal debt minus cash | $1.1B | -$105M |
| Cash & Equiv.Liquid assets | $22M | $105M |
| Total DebtShort + long-term debt | $1.1B | $0 |
| Interest CoverageEBIT ÷ Interest expense | -1.78x | -0.19x |
Total Returns (with DRIP)
A $10,000 investment in DHC five years ago would be worth $14,904 today (with dividends reinvested), compared to $10,678 for NHPBP. Over the past 12 months, DHC leads with a +140.3% total return vs NHPBP's +47.6%. The 3-year compound annual growth rate (CAGR) favors DHC at 91.5% vs NHPBP's 2.9% — a key indicator of consistent wealth creation.
| Metric | NHPBPNational Healthca… | DHCDiversified Healt… |
|---|---|---|
| YTD ReturnYear-to-date | +7.2% | +35.9% |
| 1-Year ReturnPast 12 months | +47.6% | +140.3% |
| 3-Year ReturnCumulative with dividends | +9.0% | +602.0% |
| 5-Year ReturnCumulative with dividends | +6.8% | +49.0% |
| 10-Year ReturnCumulative with dividends | +6.8% | -21.4% |
| CAGR (3Y)Annualised 3-year return | +2.9% | +91.5% |
Risk & Volatility
NHPBP is the less volatile stock with a 0.44 beta — it tends to amplify market swings less than DHC's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | NHPBPNational Healthca… | DHCDiversified Healt… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.44x | 0.75x |
| 52-Week HighHighest price in past year | $19.11 | $6.85 |
| 52-Week LowLowest price in past year | $11.77 | $2.00 |
| % of 52W HighCurrent price vs 52-week peak | +98.4% | +98.7% |
| RSI (14)Momentum oscillator 0–100 | 48.9 | 68.1 |
| Avg Volume (50D)Average daily shares traded | 6K | 1.4M |
Analyst Outlook
| Metric | NHPBPNational Healthca… | DHCDiversified Healt… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $5.00 |
| # AnalystsCovering analysts | — | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 3 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | — | +0.1% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Oct 21 | Feb 26 | Change |
|---|---|---|---|
| National Healthcare… (NHPBP) | 100 | 76.21 | -23.8% |
| Diversified Healthc… (DHC) | 100 | 152.48 | +52.5% |
Diversified Healthc… (DHC) returned +49% over 5 years vs National Healthcare… (NHPBP)'s +7%. A $10,000 investment in DHC 5 years ago would be worth $14,904 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| National Healthcare… (NHPBP) | $375M | $354M | -5.6% |
| Diversified Healthc… (DHC) | $1.1B | $1.5B | +45.4% |
Diversified Healthcare Trust's revenue grew from $1.1B (2016) to $1.5B (2025) — a 4.2% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| National Healthcare… (NHPBP) | -23.4% | -53.6% | -128.7% |
| Diversified Healthc… (DHC) | 13.4% | -18.6% | -239.2% |
Diversified Healthcare Trust's net margin went from 13% (2016) to -19% (2025).
Chart 4P/E Ratio History — 3 Years
| Stock | 2017 | 2021 | Change |
|---|---|---|---|
| Diversified Healthc… (DHC) | 30.9 | 4.2 | -86.4% |
Diversified Healthcare Trust has traded in a 4x–31x P/E range over 3 years; current trailing P/E is ~-6x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| National Healthcare… (NHPBP) | 0 | 0 | — |
| Diversified Healthc… (DHC) | 0.6 | -1.19 | -298.3% |
Diversified Healthcare Trust's EPS grew from $0.60 (2016) to $-1.19 (2025) — a NaN% CAGR.
Chart 6Free Cash Flow — 5 Years
National Healthcare Properties, Inc. generated $-102M FCF in 2024 (-614% vs 2021). Diversified Healthcare Trust generated $-20M FCF in 2025 (+69% vs 2021).
NHPBP vs DHC: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is NHPBP or DHC a better buy right now?
Analysts rate Diversified Healthcare Trust (DHC) a "Hold" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NHPBP or DHC?
Over the past 5 years, Diversified Healthcare Trust (DHC) delivered a total return of +49.0%, compared to +6.8% for National Healthcare Properties, Inc. (NHPBP). A $10,000 investment in DHC five years ago would be worth approximately $15K today (assuming dividends reinvested). Over 10 years, the gap is even starker: NHPBP returned +6.8% versus DHC's -21.4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NHPBP or DHC?
By beta (market sensitivity over 5 years), National Healthcare Properties, Inc. (NHPBP) is the lower-risk stock at 0.44β versus Diversified Healthcare Trust's 0.75β — meaning DHC is approximately 73% more volatile than NHPBP relative to the S&P 500.
04Which has better profit margins — NHPBP or DHC?
Diversified Healthcare Trust (DHC) is the more profitable company, earning -18.6% net margin versus -53.6% for National Healthcare Properties, Inc. — meaning it keeps -18.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DHC leads at -2.6% versus -34.9% for NHPBP. At the gross margin level — before operating expenses — NHPBP leads at 37.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — NHPBP or DHC?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is NHPBP or DHC better for a retirement portfolio?
For long-horizon retirement investors, National Healthcare Properties, Inc. (NHPBP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.44)). Both have compounded well over 10 years (NHPBP: +6.8%, DHC: -21.4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between NHPBP and DHC?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.